UPDATE : Tuesday, March 19, 2019
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs
AbbVies’s new hepatitis C therapy Mavyret (glecaprevir/pibrentasvir), a fol...
by Kim Yun-mi  |  2019-02-12 15:56
Pfizer Korea voluntarily recalls antibiotic Zyvox
Pfizer Korea said it voluntarily recalled some of Zyvox 600mg (ingredient: ...
by Lee Hye-seon  |  2019-02-12 15:56
SK Chemical to co-promote Janssen’s dementia treatment
SK Chemical said Tuesday that it has signed an agreement with Janssen Korea...
by Lee Han-soo  |  2019-02-12 15:55
Demands for MMR vaccines spike amid resurgence of measles
Amid a rise of measles patients, clinics are suffering a shortage of MMR (m...
by Park Gi-taek  |  2019-02-12 11:19
IVI to cooperate with CEPI to develop vaccines
International Vaccine Institute (IVI) said it has signed a partner service ...
by Lee Han-soo  |  2019-02-11 16:41
Gilead’s hepatitis B drug posts disappointing sales in 2018
Gilead Sciences Korea’s hepatitis B treatment Vemlidy (ingredient: tenofovi...
by Kim Yun-mi  |  2019-02-11 15:29
Sales of antidiabetic SGLT-2 inhibitors expand 40% in 2018
Sales of antidiabetic drugs using sodium-glucose cotransporter 2 (SGLT-2) i...
by Kim Yun-mi  |  2019-02-11 14:35
Novo Nordisk has high expectations for GLP-1 receptor agonists
Novo Nordisk is confident that 2019 will be another good business year ridi...
by Kim Yun-mi  |  2019-02-08 17:11
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list
Bioneer said its human immunodeficiency virus type 1 (HIV-1) diagnostic kit...
by Park Gi-taek  |  2019-02-08 16:46
Pangen wins Malaysia’s nod for epoetin alfa biosimilar
Pangen said Thursday that Malaysia’s National Pharmaceutical Regulatory Age...
by Lee Han-soo  |  2019-02-08 16:13
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea
Sanofi is preparing to seek an additional indication of Praluent (alirocuma...
by Kim Yun-mi  |  2019-02-08 16:12
Multinationals prepare next-generation pneumococcal vaccines
Multinational pharmaceutical firms are gearing up to replace conventional p...
by Kim Yun-mi  |  2019-02-08 12:02
Kainos Medicine starts developing treatment for multiple system atrophy
Kainos Medicine said Friday that it would develop a treatment for multiple ...
by Lee Han-soo  |  2019-02-08 11:47
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’
Novartis said Thursday that Cosentyx (Ingredient: secukinumab), its interle...
by Lee Han-soo  |  2019-02-07 17:14
Seoul accepts Bayer’s request to reduce study subjects of cancer drug
The government has accepted Bayer’s request to reduce the number of review ...
by Lee Hye-seon  |  2019-02-07 16:06
FDA starts inspecting SK Biopharm’s epilepsy treatment
SK Biopharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Lee Han-soo  |  2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo  |  2019-02-07 14:40
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi  |  2019-02-07 14:40
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo  |  2019-02-07 11:09
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo  |  2019-02-01 17:04
Back to Top